1 withdrawn. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Withdrawn 1 |
Follow Relapse: new trials by email Literature Review of Relapse trials Research Report on Relapse
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Epacadostat, Cladribine and Cytarabine (ECC) in AML Epacadostat, Cladribine, Cytarabine - AML, Relapse | Phase 1 | Withdrawn | Insel Gruppe AG, University Hospital Bern | 2018-12-01 | 2018-09-11 |
Recurrence (1)
Disease Attributes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Cladribine (1) · Cytarabine (1) · epacadostat (1)
Insel Gruppe AG, University Hospital Bern (1)
Switzerland (1)